Researchers discuss the role of extracellular vesicles as a potential link between obesity and Alzheimer’s disease.

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. Well, currently we have three FDA approved ...

A CRISPR-Cas9-based therapy targeting the gene encoding transthyretin greatly reduced transthyretin levels in patients with ...

In a study published in the Proceedings of the National Academy of Sciences, researchers have revealed that amyloid fibrils formed by necroptosis mediators, RIPK1 and RIPK3, don't just form within ...

At least one-fifth of all people on the planet are carrying a gene variant that predisposes them to Alzheimer's. Known as ...

If there's one thing that's crystal clear about Alzheimer's disease, it's this: It eats away at neurons and the links between them, ultimately destroying the neural networks that underlie our memories ...

TORONTO -- An investigational antibody drug, designed to cross the blood-brain barrier (BBB) to eliminate amyloid-beta plaques associated with Alzheimer's disease, performed so well in a phase Ib/IIa ...

Transthyretin cardiac amyloidosis (ATTR-CA) is a frequent cause of heart failure (HF) in older Black individuals, particularly in the oldest men, the prospective SCAN-MP study affirms. The highest ...

Traditional tax-deferred account types is where the RMD will apply. The notable exception is anything with a Roth tag applied to it. The age for RMDs had been stuck at 70 and a half for many years. It ...

CAMBRIDGE, Mass., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based ...

Obesity has long been acknowledged as a risk factor for a wide range of diseases, but a more precise link between obesity and Alzheimer's disease has remained a mystery – until now.